🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "focused action to address household expense challenges" in the forthcoming financial statement.

In comments to media outlets, she emphasized that reducing inflation is a joint responsibility of both the administration and the central bank.

The UK's price growth is forecast to be the most elevated among the G7 developed nations this calendar year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to lower energy bills, for example by slashing the current 5% rate of value-added tax applied on energy.

Another approach is to reduce some of the policy costs presently added to household expenses.

Budgetary Limitations and Expert Predictions

The administration will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for such measures.

The consensus from most economists is that the Chancellor will have to introduce tax rises or expenditure reductions in order to fulfill her voluntary debt limits.

Earlier on the same day, estimates indicated there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of forecasts.

"There's a joint task between the Bank of England and the government to continue tackling some of the causes of inflation," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on probable tax rises, the chancellor said the most recent data from the fiscal watchdog had not changed her vow to election pledges not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing geopolitical and trade concerns for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Referring to apprehensions about the United Kingdom's trade ties with China she said: "The UK's national security invariably take priority."

Last week's statement by Chinese authorities to tighten export controls on critical minerals and other resources that are essential for advanced tech production led US President Donald Trump to suggest an extra 100% import tax on goods from the Asian country, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief labeled China's action "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the US offer to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "bad for the global economy and causes additional headwinds."

"It is my opinion there are areas where we need to address Chinese policies, but there are also valuable prospects to export to China's economy, including banking sector and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was collaborating with international partners "regarding our own critical minerals approach, so that we are reduced dependence."

Health Service Medicine Costs and Funding

Reeves also acknowledged that the price the NHS pays for pharmaceuticals could go up as a consequence of ongoing negotiations with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or scrapping operations in the United Kingdom, with several attributing the low prices they are getting.

Recently, the government science advisor said the cost the NHS pays for drugs would need to go up to prevent firms and pharmaceutical investment leaving the UK.

Reeves told the BBC: "It has been observed because of the cost structure, that medical research, new drugs have not been offered in the United Kingdom in the extent that they are in other continental states."

"We want to ensure that individuals getting treatment from the National Health Service are able to obtain the top critical drugs in the globe. And so we are looking at all of that, and... aiming to attract increased funding into Britain."